Not yet recruitingNCT07529236
Digestive Evolution of Children With Crohn's Disease or Ulcerative Colitis Whose Anti-TNFα Treatment Was Switched to Ustekinumab Due to Paradoxical Psoriasis,
Studying Wiskott-Aldrich syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Principal Investigator
- Christine CHIAVERINICentre Hospitalier Universitaire de Nice
- Intervention
- switch of anti TNF for ustekinumab for paradoxical psoriasis.(drug)
- Enrollment
- 40 target
- Eligibility
- 6-17 years · All sexes
- Timeline
- 2026 – 2027
Study locations (1)
- CHU de Nice, Nice, France, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07529236 on ClinicalTrials.govOther trials for Wiskott-Aldrich syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07534033Phase II Clinical Study of Probiotic LR607 in Patients With Non-Small Cell Lung CancerZhujiang Hospital
- ACTIVE NOT RECRUITINGPHASE3NCT03837483A Clinical Study to Evaluate the Use of a Cryopreserved Formulation of OTL-103 in Subjects With Wiskott-Aldrich SyndromeFondazione Telethon
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT02333760Long Term Safety Follow up of Haematopoietic Stem Cell Gene Therapy for the Wiskott Aldrich SyndromeGenethon